Northern Trust Corp Mainz Biomed N.V. Transaction History
Northern Trust Corp
- $572 Billion
- Q1 2024
A detailed history of Northern Trust Corp transactions in Mainz Biomed N.V. stock. As of the latest transaction made, Northern Trust Corp holds 29,934 shares of MYNZ stock, worth $11,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,934
Previous 33,082
9.52%
Holding current value
$11,374
Previous $38,000
21.05%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MYNZ
# of Institutions
13Shares Held
147KCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X028.8KShares$10,9340.0% of portfolio
-
Vontobel Holding Ltd.25KShares$9,5000.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il18.2KShares$6,8990.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.2KShares$5,7710.0% of portfolio
-
Greenwich Investment Management, Inc. Stamford, CT12KShares$4,5530.01% of portfolio
About MAINZ BIOMED N.V.
- Ticker MYNZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 14,483,000
- Market Cap $5.5M
- Description
- Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...